Related Experiment Video
Updated: May 19, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Atypical neuropathological sCJD-MM phenotype with abundant white matter Kuru-type plaques sparing the cerebellar
Ellen Gelpi1, Josep Ma Soler Insa, Piero Parchi
1Neurological Tissue Bank of the Biobank-Hospital Clinic-IDIBAPS, Facultat de Medicina, Spain. ellen.gelpi@gmail.com
Abstract:
We describe an atypical neuropatholgical phenotype of sporadic Creutzfeldt-Jakob disease (sCJD) in a 64-year-old man presenting with a 5-month history of rapidly progressive dementia, comprising behavioral disturbances, memory complaints, disorientation and language alterations. MRI showed diffuse atrophy and hyperintensities in parietal, occipital, temporal and frontal cortices and left caudate nucleus on T2-weighted and fluid-attenuated inversion recovery images. No typical EEG alterations were observed. Repeated 14-3-3 assay was positive after a first negative test. Neuropathology showed classical CJD changes with small cortical foci of large confluent vacuoles and relatively well-preserved cerebellar cortex. The most striking feature was the presence of abundant Kuru-type plaques in both cerebral cortex and subcortical white matter. Sparse Kuru-type plaques were also seen in cerebellum, although only in white matter. Immunohistochemistry showed, in addition to unicentric plaques, diffuse synaptic and patchy perivacuolar, as well as plaque-like and periaxonal pathological prion protein deposits (PrP(res) ). Western blot studies demonstrated the co-occurrence of PrP(res) types 1 and 2 in frontal cortex and a relatively weak type 2 signal in cerebellum. PRNP genotyping revealed methionine homozygosity at codon 129 and excluded mutations. This case shows a previously undescribed combination of histopathological features which preclude its classification according to the current phenotypic and molecular sCJD classification. The observation demonstrates that Kuru-type amyloid plaques mainly involving the cerebral white matter may also occur in sCJD cases with short clinical course and the co-existence of PrP(res) types 1 and 2. This case further highlights the complexity of the correlations between histopathological phenotype and PrP(res) isotype in prion diseases.
Insights
This study details an unusual case of sporadic Creutzfeldt-Jakob disease (sCJD) with Kuru-type plaques and co-existing prion protein types, highlighting diagnostic complexities.
Area of Science:
- Neuropathology
- Prion Diseases
- Neurodegenerative Disorders
Background:
- Sporadic Creutzfeldt-Jakob disease (sCJD) is a fatal prion disease characterized by rapidly progressive dementia.
- Typical neuropathological findings include spongiform changes and prion protein (PrP) deposits.
- Classification of sCJD subtypes relies on molecular and histopathological features.
Observation:
- A 64-year-old man presented with rapidly progressive dementia and atypical MRI findings.
- Neuropathology revealed classical CJD changes alongside abundant Kuru-type plaques, particularly in white matter.
- Immunohistochemistry and Western blot showed co-existing PrP(res) types 1 and 2.
Findings:
- The case presented a unique combination of histopathological features, including widespread Kuru-type plaques in cerebral white matter.
- This phenotype did not fit current sCJD classification criteria.
- Co-occurrence of PrP(res) types 1 and 2 was confirmed in the frontal cortex.
Implications:
- This case expands the known histopathological spectrum of sporadic Creutzfeldt-Jakob disease.
- It underscores the complexity of prion protein isotype and histopathological phenotype correlations.
- Highlights the need for comprehensive diagnostic approaches in atypical prion disease presentations.
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Huntington Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Alzheimer Disease l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Cerebral Edema ll: Pathophysiology

